BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 15916971)

  • 1. Efficacy of photocrosslinkable chitosan hydrogel containing fibroblast growth factor-2 in a rabbit model of chronic myocardial infarction.
    Fujita M; Ishihara M; Morimoto Y; Simizu M; Saito Y; Yura H; Matsui T; Takase B; Hattori H; Kanatani Y; Kikuchi M; Maehara T
    J Surg Res; 2005 Jun; 126(1):27-33. PubMed ID: 15916971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic angiogenesis induced by controlled release of fibroblast growth factor-2 from injectable chitosan/non-anticoagulant heparin hydrogel in a rat hindlimb ischemia model.
    Fujita M; Ishihara M; Shimizu M; Obara K; Nakamura S; Kanatani Y; Morimoto Y; Takase B; Matsui T; Kikuchi M; Maehara T
    Wound Repair Regen; 2007; 15(1):58-65. PubMed ID: 17244320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Controlled release of fibroblast growth factors and heparin from photocrosslinked chitosan hydrogels and subsequent effect on in vivo vascularization.
    Ishihara M; Obara K; Ishizuka T; Fujita M; Sato M; Masuoka K; Saito Y; Yura H; Matsui T; Hattori H; Kikuchi M; Kurita A
    J Biomed Mater Res A; 2003 Mar; 64(3):551-9. PubMed ID: 12579570
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intramyocardial sustained delivery of basic fibroblast growth factor improves angiogenesis and ventricular function in a rat infarct model.
    Iwakura A; Fujita M; Kataoka K; Tambara K; Sakakibara Y; Komeda M; Tabata Y
    Heart Vessels; 2003 May; 18(2):93-9. PubMed ID: 12756606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of basic fibroblast growth factor microspheres on angiogenesis in ischemic myocardium and cardiac function: analysis with dobutamine cardiovascular magnetic resonance tagging.
    Liu Y; Sun L; Huan Y; Zhao H; Deng J
    Eur J Cardiothorac Surg; 2006 Jul; 30(1):103-7. PubMed ID: 16730451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acceleration of wound healing in healing-impaired db/db mice with a photocrosslinkable chitosan hydrogel containing fibroblast growth factor-2.
    Obara K; Ishihara M; Fujita M; Kanatani Y; Hattori H; Matsui T; Takase B; Ozeki Y; Nakamura S; Ishizuka T; Tominaga S; Hiroi S; Kawai T; Maehara T
    Wound Repair Regen; 2005; 13(4):390-7. PubMed ID: 16008728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The interaction of chitosan with fibroblast growth factor-2 and its protection from inactivation.
    Masuoka K; Ishihara M; Asazuma T; Hattori H; Matsui T; Takase B; Kanatani Y; Fujita M; Saito Y; Yura H; Fujikawa K; Nemoto K
    Biomaterials; 2005 Jun; 26(16):3277-84. PubMed ID: 15603823
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of controlled release of fibroblast growth factor-2 from chitosan/fucoidan micro complex-hydrogel on in vitro and in vivo vascularization.
    Nakamura S; Nambu M; Ishizuka T; Hattori H; Kanatani Y; Takase B; Kishimoto S; Amano Y; Aoki H; Kiyosawa T; Ishihara M; Maehara T
    J Biomed Mater Res A; 2008 Jun; 85(3):619-27. PubMed ID: 17806115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intrapericardial delivery of fibroblast growth factor-2 induces neovascularization in a porcine model of chronic myocardial ischemia.
    Laham RJ; Rezaee M; Post M; Novicki D; Sellke FW; Pearlman JD; Simons M; Hung D
    J Pharmacol Exp Ther; 2000 Feb; 292(2):795-802. PubMed ID: 10640320
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of high-pressure retrograde coronary venous delivery of FGF-2 protein.
    Fearon WF; Ikeno F; Bailey LR; Hiatt BL; Herity NA; Carter AJ; Fitzgerald PJ; Rezaee M; Yeung AC; Yock PG
    Catheter Cardiovasc Interv; 2004 Mar; 61(3):422-8. PubMed ID: 14988909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of the cardiac angiogenic response to surgical FGF-2 therapy in a Swine endothelial dysfunction model.
    Ruel M; Wu GF; Khan TA; Voisine P; Bianchi C; Li J; Li J; Laham RJ; Sellke FW
    Circulation; 2003 Sep; 108 Suppl 1():II335-40. PubMed ID: 12970256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved myocardial performance in infarcted rat heart by co-injection of basic fibroblast growth factor with temperature-responsive chitosan hydrogel.
    Wang H; Zhang X; Li Y; Ma Y; Zhang Y; Liu Z; Zhou J; Lin Q; Wang Y; Duan C; Wang C
    J Heart Lung Transplant; 2010 Aug; 29(8):881-7. PubMed ID: 20466563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intramyocardial injection of low-dose basic fibroblast growth factor or vascular endothelial growth factor induces angiogenesis in the infarcted rabbit myocardium.
    Bougioukas I; Didilis V; Ypsilantis P; Giatromanolaki A; Sivridis E; Lialiaris T; Mikroulis D; Simopoulos C; Bougioukas G
    Cardiovasc Pathol; 2007; 16(2):63-8. PubMed ID: 17317537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Application of bFGF and BDNF to improve angiogenesis and cardiac function.
    Liu Y; Sun L; Huan Y; Zhao H; Deng J
    J Surg Res; 2006 Nov; 136(1):85-91. PubMed ID: 16904693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gelatin hydrogel microspheres enable pinpoint delivery of basic fibroblast growth factor for the development of functional collateral vessels.
    Hosaka A; Koyama H; Kushibiki T; Tabata Y; Nishiyama N; Miyata T; Shigematsu H; Takato T; Nagawa H
    Circulation; 2004 Nov; 110(21):3322-8. PubMed ID: 15520306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Controlled release of fibroblast growth factor-2 from an injectable 6-O-desulfated heparin hydrogel and subsequent effect on in vivo vascularization.
    Nakamura S; Ishihara M; Obara K; Masuoka K; Ishizuka T; Kanatani Y; Takase B; Matsui T; Hattori H; Sato T; Kariya Y; Maehara T
    J Biomed Mater Res A; 2006 Aug; 78(2):364-71. PubMed ID: 16673389
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A strategy of retrograde injection of bone marrow mononuclear cells into the myocardium for the treatment of ischemic heart disease.
    Yokoyama S; Fukuda N; Li Y; Hagikura K; Takayama T; Kunimoto S; Honye J; Saito S; Wada M; Satomi A; Kato M; Mugishima H; Kusumi Y; Mitsumata M; Murohara T
    J Mol Cell Cardiol; 2006 Jan; 40(1):24-34. PubMed ID: 16271723
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Co-delivery of FGF-2 and G-CSF from gelatin-based hydrogels as angiogenic therapy in a murine critical limb ischemic model.
    Layman H; Sacasa M; Murphy AE; Murphy AM; Pham SM; Andreopoulos FM
    Acta Biomater; 2009 Jan; 5(1):230-9. PubMed ID: 18713669
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calreticulin downregulation is associated with FGF-2-induced angiogenesis through calcineurin pathway in ischemic myocardium.
    Liu X; Wu X; Cai L; Sun S
    Shock; 2008 Jan; 29(1):140-8. PubMed ID: 17693930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Controlled release of paclitaxel from photocrosslinked chitosan hydrogels and its subsequent effect on subcutaneous tumor growth in mice.
    Obara K; Ishihara M; Ozeki Y; Ishizuka T; Hayashi T; Nakamura S; Saito Y; Yura H; Matsui T; Hattori H; Takase B; Ishihara M; Kikuchi M; Maehara T
    J Control Release; 2005 Dec; 110(1):79-89. PubMed ID: 16289419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.